The healthcare landscape for blood sugar is evolving, and these patches represent a potential breakthrough. Unlike injections, this approach offers a more convenient here way to deliver GLP-1 medications. These transdermal systems gradually release the treatment through the epidermis offering a stable amount of the beneficial agent, which can enhan